OBIO News, Ontario Industry Updates Arsheen Kaur 8/26/25 OBIO News, Ontario Industry Updates Arsheen Kaur 8/26/25 A4i spotlighted in The Globe and Mail Read More OBIO News, Ontario Industry Updates Arsheen Kaur 8/19/25 OBIO News, Ontario Industry Updates Arsheen Kaur 8/19/25 Ontario invests $5M to boost life sciences in Ottawa Read More OBIO News, Ontario Industry Updates Arsheen Kaur 8/12/25 OBIO News, Ontario Industry Updates Arsheen Kaur 8/12/25 Sudbury medtech device approved for sale in India Read More OBIO News, Ontario Industry Updates Arsheen Kaur 8/12/25 OBIO News, Ontario Industry Updates Arsheen Kaur 8/12/25 ProteinQure receives regulatory clearance to initiate Phase I Trial for PQ203 in the U.S. and Canada; Granted FDA Fast Track Designation Read More OBIO News Doriane Rey 8/6/25 OBIO News Doriane Rey 8/6/25 A Joint Call To Action For Canada’s Life Sciences Future from the National Biotech Accord Read More OBIO News, Ontario Industry Updates Arsheen Kaur 7/29/25 OBIO News, Ontario Industry Updates Arsheen Kaur 7/29/25 Dalriada announces strategic collaboration on iCLASS Platform with a public computational company Read More OBIO News, Ontario Industry Updates Arsheen Kaur 7/15/25 OBIO News, Ontario Industry Updates Arsheen Kaur 7/15/25 Katalyze AI launches Digityze AI on Snowflake AI Data Cloud, enabling GMP-ready intelligence for biomanufacturing Read More OBIO News, Ontario Industry Updates Arsheen Kaur 7/15/25 OBIO News, Ontario Industry Updates Arsheen Kaur 7/15/25 FluidAI secures a $2 Million Government of Canada investment to accelerate global commercialization of AI-driven post operative care technology Read More OBIO News, Ontario Industry Updates Arsheen Kaur 7/15/25 OBIO News, Ontario Industry Updates Arsheen Kaur 7/15/25 Cobionix secures US $3 Million in strategic funding to advance autonomous medical robotics Read More OBIO News, Ontario Industry Updates Arsheen Kaur 7/15/25 OBIO News, Ontario Industry Updates Arsheen Kaur 7/15/25 New adMare white paper maps capital flows in Canadian life sciences, urges policy shift Read More OBIO News, Ontario Industry Updates Arsheen Kaur 6/30/25 OBIO News, Ontario Industry Updates Arsheen Kaur 6/30/25 LSO launches new report calling for urgent actionto bridge critical funding gap threatening Ontario's innovation leadership Read More OBIO News, Ontario Industry Updates Arsheen Kaur 6/30/25 OBIO News, Ontario Industry Updates Arsheen Kaur 6/30/25 Flosonics’ FloPatch expands to East Coast Read More OBIO News, Ontario Industry Updates Arsheen Kaur 6/30/25 OBIO News, Ontario Industry Updates Arsheen Kaur 6/30/25 OBIO® companies recognized in Betakit's new report Read More OBIO News, Ontario Industry Updates Arsheen Kaur 6/30/25 OBIO News, Ontario Industry Updates Arsheen Kaur 6/30/25 Atorvia shines in the latest edition of BIOTECanada's INSIGHTS magazine Read More OBIO News, Ontario Industry Updates Arsheen Kaur 6/17/25 OBIO News, Ontario Industry Updates Arsheen Kaur 6/17/25 OBIO® x CATTI's biomanufacturing initiative featured in BIOTECanada's INSIGHTS magazine Read More OBIO News, Ontario Industry Updates Arsheen Kaur 6/17/25 OBIO News, Ontario Industry Updates Arsheen Kaur 6/17/25 Spiderwort Biotech receives Health Canada Investigational Testing Authorization for CelluJuve® Read More OBIO News, Ontario Industry Updates Arsheen Kaur 6/17/25 OBIO News, Ontario Industry Updates Arsheen Kaur 6/17/25 Hyivy Health spotlighted in this feature by the Canadian Medical Association Read More OBIO News, Ontario Industry Updates Arsheen Kaur 6/17/25 OBIO News, Ontario Industry Updates Arsheen Kaur 6/17/25 Stem Cell Network announces $33M to advance regenerative medicine research and clinical trials Read More OBIO News, Ontario Industry Updates Arsheen Kaur 6/4/25 OBIO News, Ontario Industry Updates Arsheen Kaur 6/4/25 ToeFX Featured on Global News Health Matters Segment Read More OBIO News, Ontario Industry Updates Arsheen Kaur 6/4/25 OBIO News, Ontario Industry Updates Arsheen Kaur 6/4/25 Satellos Announces Promising Phase 1b Trial Results of SAT-3247 in Adults with Duchenne Muscular Dystrophy Read More Newer Posts Older Posts
OBIO News, Ontario Industry Updates Arsheen Kaur 8/26/25 OBIO News, Ontario Industry Updates Arsheen Kaur 8/26/25 A4i spotlighted in The Globe and Mail Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 8/19/25 OBIO News, Ontario Industry Updates Arsheen Kaur 8/19/25 Ontario invests $5M to boost life sciences in Ottawa Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 8/12/25 OBIO News, Ontario Industry Updates Arsheen Kaur 8/12/25 Sudbury medtech device approved for sale in India Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 8/12/25 OBIO News, Ontario Industry Updates Arsheen Kaur 8/12/25 ProteinQure receives regulatory clearance to initiate Phase I Trial for PQ203 in the U.S. and Canada; Granted FDA Fast Track Designation Read More
OBIO News Doriane Rey 8/6/25 OBIO News Doriane Rey 8/6/25 A Joint Call To Action For Canada’s Life Sciences Future from the National Biotech Accord Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 7/29/25 OBIO News, Ontario Industry Updates Arsheen Kaur 7/29/25 Dalriada announces strategic collaboration on iCLASS Platform with a public computational company Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 7/15/25 OBIO News, Ontario Industry Updates Arsheen Kaur 7/15/25 Katalyze AI launches Digityze AI on Snowflake AI Data Cloud, enabling GMP-ready intelligence for biomanufacturing Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 7/15/25 OBIO News, Ontario Industry Updates Arsheen Kaur 7/15/25 FluidAI secures a $2 Million Government of Canada investment to accelerate global commercialization of AI-driven post operative care technology Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 7/15/25 OBIO News, Ontario Industry Updates Arsheen Kaur 7/15/25 Cobionix secures US $3 Million in strategic funding to advance autonomous medical robotics Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 7/15/25 OBIO News, Ontario Industry Updates Arsheen Kaur 7/15/25 New adMare white paper maps capital flows in Canadian life sciences, urges policy shift Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 6/30/25 OBIO News, Ontario Industry Updates Arsheen Kaur 6/30/25 LSO launches new report calling for urgent actionto bridge critical funding gap threatening Ontario's innovation leadership Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 6/30/25 OBIO News, Ontario Industry Updates Arsheen Kaur 6/30/25 Flosonics’ FloPatch expands to East Coast Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 6/30/25 OBIO News, Ontario Industry Updates Arsheen Kaur 6/30/25 OBIO® companies recognized in Betakit's new report Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 6/30/25 OBIO News, Ontario Industry Updates Arsheen Kaur 6/30/25 Atorvia shines in the latest edition of BIOTECanada's INSIGHTS magazine Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 6/17/25 OBIO News, Ontario Industry Updates Arsheen Kaur 6/17/25 OBIO® x CATTI's biomanufacturing initiative featured in BIOTECanada's INSIGHTS magazine Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 6/17/25 OBIO News, Ontario Industry Updates Arsheen Kaur 6/17/25 Spiderwort Biotech receives Health Canada Investigational Testing Authorization for CelluJuve® Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 6/17/25 OBIO News, Ontario Industry Updates Arsheen Kaur 6/17/25 Hyivy Health spotlighted in this feature by the Canadian Medical Association Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 6/17/25 OBIO News, Ontario Industry Updates Arsheen Kaur 6/17/25 Stem Cell Network announces $33M to advance regenerative medicine research and clinical trials Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 6/4/25 OBIO News, Ontario Industry Updates Arsheen Kaur 6/4/25 ToeFX Featured on Global News Health Matters Segment Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 6/4/25 OBIO News, Ontario Industry Updates Arsheen Kaur 6/4/25 Satellos Announces Promising Phase 1b Trial Results of SAT-3247 in Adults with Duchenne Muscular Dystrophy Read More
